4 reports

In April 2016, EA Pharma Co., Ltd. established by integration of the gastrointestinal business unit of the Eisai Group and the Ajinomoto Group s gastrointestinal business unit with the core in amino acid.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Japan
  • Product Initiative
  • Albireo Limited
  • ZS-07 - DRUG PROFILE
  • YH-12852 - DRUG PROFILE

It inhibits peripheral acetylcholinesterase activities in the gastrointestinal tract.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • Japan
  • RaQualia Pharma Inc.
  • YH-12852 - DRUG PROFILE

It inhibits peripheral acetylcholinesterase activities in the gastrointestinal tract.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Japan
  • Product Initiative
  • RaQualia Pharma Inc.

For Gastrointestinal Therapies.

  • Gastrointestinal Drug
  • Pharmaceutical
  • Japan
  • Product Initiative
  • RaQualia Pharma Inc.